Myocarsdial-derived miR-29a-regulated DNMTs: A novel therapeutic target for myocardial fibrosis

Affiliations

¹ Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang 443003, China; Institute of Cardiovascular Diseases, China Three Gorges University, Yichang 443000, China; HuBei Clinical Research Center for Ischemic Cardiovascular Disease, China.
² Institute of Cardiovascular Diseases, China Three Gorges University, Yichang 443000, China; HuBei Clinical Research Center for Ischemic Cardiovascular Disease, China.
³ Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang 443003, China; Institute of Cardiovascular Diseases, China Three Gorges University, Yichang 443000, China; HuBei Clinical Research Center for Ischemic Cardiovascular Disease, China. Electronic address: yangjian@ctgu.edu.cn.

Comment

Di Wu et al. Int J Cardiol. 2022.

. 2022 Jul 1:358:76.

doi: 10.1016/j.ijcard.2022.04.049. Epub 2022 Apr 19.

¹ Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang 443003, China; Institute of Cardiovascular Diseases, China Three Gorges University, Yichang 443000, China; HuBei Clinical Research Center for Ischemic Cardiovascular Disease, China.
² Institute of Cardiovascular Diseases, China Three Gorges University, Yichang 443000, China; HuBei Clinical Research Center for Ischemic Cardiovascular Disease, China.
³ Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang 443003, China; Institute of Cardiovascular Diseases, China Three Gorges University, Yichang 443000, China; HuBei Clinical Research Center for Ischemic Cardiovascular Disease, China. Electronic address: yangjian@ctgu.edu.cn.

No abstract available

Comment in

Reply to the letter "Myocardial-derived miR-29a-regulated DNMTs: A novel therapeutic target for myocardial fibrosis".
Scolari FL, Biolo A. Scolari FL, et al. Int J Cardiol. 2022 Oct 1;364:95. doi: 10.1016/j.ijcard.2022.06.002. Epub 2022 Jun 3. Int J Cardiol. 2022. PMID: 35660555 No abstract available.

A systematic review of microRNAs in patients with hypertrophic cardiomyopathy.
Scolari FL, Faganello LS, Garbin HI, Piva E Mattos B, Biolo A. Scolari FL, et al. Int J Cardiol. 2021 Mar 15;327:146-154. doi: 10.1016/j.ijcard.2020.11.004. Epub 2020 Nov 16. Int J Cardiol. 2021. PMID: 33212095